Literature DB >> 17652898

Decreased lipoprotein lipase in obstructive sleep apnea syndrome.

Ken Iesato1, Koichiro Tatsumi, Toshiji Saibara, Akira Nakamura, Jiro Terada, Yuji Tada, Seiichiro Sakao, Nobuhiro Tanabe, Yuichi Takiguchi, Takayuki Kuriyama.   

Abstract

BACKGROUND: Lipoprotein lipase (LPL) might play a major role in lipid metabolism by hydrolyzing triglyceride-rich lipoproteins. Decreased LPL activity can trigger early inflammatory responses central to atherosclerosis. However, whether repeated apnea-related hypoxemia influences lipid metabolism in patients with obstructive sleep apnea syndrome (OSAS) remain undefined. This investigation determined whether circulating LPL was influenced by repeated apnea-related hypoxemia, and the effect of nasal continuous positive airway pressure (CPAP) therapy on LPL concentrations in OSAS patients. METHODS AND
RESULTS: The participants of the study were 155 men with OSAS and 39 men without OSAS. Circulating LPL concentrations decreased with the severity of OSAS. They correlated negatively with serum triglyceride, and the linear regression lines between LPL concentrations and triglyceride in OSAS patients were shifted downward compared with those in non-OSAS patients, suggesting that any pathophysiological factor might decrease LPL activity in OSAS patients. Some OSAS patients were subjected to CPAP therapy for 3 months. CPAP therapy increased LPL concentrations and decreased C-reactive protein (CRP) concentrations.
CONCLUSIONS: The present study suggests that repeated apnea-related hypoxemia might affect lipid metabolism and augment inflammatory responses, and CPAP therapy could be effective to decrease inflammatory responses and ameliorate lipid metabolism in patients with OSAS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652898     DOI: 10.1253/circj.71.1293

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

1.  Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis.

Authors:  Yongzhong Guo; Lei Pan; Dunqiang Ren; Xiaomei Xie
Journal:  Sleep Breath       Date:  2012-06-05       Impact factor: 2.816

2.  Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism.

Authors:  Luciano F Drager; Thauany M Tavoni; Vanessa M Silva; Raul D Santos; Rodrigo P Pedrosa; Luiz A Bortolotto; Carmen G Vinagre; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho; Raul C Maranhao
Journal:  J Lipid Res       Date:  2018-04-08       Impact factor: 5.922

Review 3.  Obstructive sleep apnea: an emerging risk factor for atherosclerosis.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  Chest       Date:  2011-08       Impact factor: 9.410

Review 4.  Serum inflammatory markers in obstructive sleep apnea: a meta-analysis.

Authors:  Rashid Nadeem; Janos Molnar; Essam M Madbouly; Mahwish Nida; Saurabh Aggarwal; Hassan Sajid; Jawed Naseem; Rohit Loomba
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

5.  Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea.

Authors:  Luciano F Drager; Jianguo Li; Mi-Kyung Shin; Christian Reinke; Neil R Aggarwal; Jonathan C Jun; Shannon Bevans-Fonti; Carole Sztalryd; Sheila M O'Byrne; Olessia Kroupa; Gunilla Olivecrona; William S Blaner; Vsevolod Y Polotsky
Journal:  Eur Heart J       Date:  2011-04-09       Impact factor: 29.983

6.  Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4.

Authors:  Luciano F Drager; Qiaoling Yao; Karen L Hernandez; Mi-Kyung Shin; Shannon Bevans-Fonti; Jason Gay; Thomas E Sussan; Jonathan C Jun; Allen C Myers; Gunilla Olivecrona; Alan R Schwartz; Nils Halberg; Philipp E Scherer; Gregg L Semenza; David R Powell; Vsevolod Y Polotsky
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

Review 7.  Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis.

Authors:  Rashid Nadeem; Mukesh Singh; Mahwish Nida; Irfan Waheed; Adnan Khan; Saeed Ahmed; Jawed Naseem; Daniel Champeau
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

8.  Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea.

Authors:  Katsunori Ishida; Masahiko Kato; Yosuke Kato; Kiyotaka Yanagihara; Yoshiharu Kinugasa; Kazuhiko Kotani; Osamu Igawa; Ichiro Hisatome; Chiaki Shigemasa; Virend K Somers
Journal:  Chest       Date:  2009-03-02       Impact factor: 9.410

Review 9.  Recent Advances in Studies on the Role of Neuroendocrine Disorders in Obstructive Sleep Apnea-Hypopnea Syndrome-Related Atherosclerosis.

Authors:  Wanda Wang; Yanli Zheng; Meimei Li; Shu Lin; Huili Lin
Journal:  Nat Sci Sleep       Date:  2021-07-27

10.  Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis.

Authors:  Aaron Baessler; Rashid Nadeem; Michael Harvey; Essam Madbouly; Amna Younus; Hassan Sajid; Jawed Naseem; Asma Asif; Hasnain Bawaadam
Journal:  J Inflamm (Lond)       Date:  2013-03-22       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.